Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JYSB2101202	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2021-12-22		view
CYSB2300080	阿达木单抗注射液	adalimumab	Injection	Biological Products(原2)	Supplementary Application	2023-04-11	Shanghai Henlius Biopharmaceutical Co Ltd	view
JYSB2101039	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2021-06-02		view
JYSB2101038	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2021-06-02		view
CYSB2400050	阿达木单抗注射液	adalimumab	Injection	Biological Products(原2)	Supplementary Application	2024-02-29	Shanghai Henlius Biopharmaceutical Co Ltd	view
CYSB2200048	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2022-02-16	Innovent Biologics (Suzhou) Co Ltd	view
CYSB2200049	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2022-02-16	Innovent Biologics (Suzhou) Co Ltd	view
CYSB2200090	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2022-03-21		view
CYSB2400023	阿达木单抗注射液	adalimumab	Injection	Biological Products(原2)	Supplementary Application	2024-01-23	Hisun Biopharmaceutical Co Ltd	view
JYSZ2100520	阿达木单抗注射液	adalimumab	Injection	Biological Products	License Renew	2021-06-10		view
JYSB2101060	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2021-06-25		view
CYSB2400155	阿达木单抗注射液	adalimumab	Injection	Biological Products(原2)	Supplementary Application	2024-06-18	Hisun Biopharmaceutical Co Ltd	view
CYSB2300050	阿达木单抗注射液	adalimumab	Injection	Biological Products(3.3)	Supplementary Application	2023-02-23		view
CYSB2200046	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2022-02-15	Innovent Biologics (Suzhou) Co Ltd	view
CYSB2400051	阿达木单抗注射液	adalimumab	Injection	Biological Products(原2)	Supplementary Application	2024-02-29	Shanghai Henlius Biopharmaceutical Co Ltd	view
JYSB2101156	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2021-11-03		view
CYSB2200205	阿达木单抗注射液	adalimumab	Injection	Biological Products(3.3)	Supplementary Application	2022-08-19		view
CXSS2300100	阿达木单抗注射液	adalimumab	Injection	Biological Products(3.3)	New Drug Application	2023-12-19	Wuhan Institute of Biological Products Co Ltd	view
CXSS2101064	阿达木单抗注射液	adalimumab	Injection	Biological Products(3.3)	New Drug Application	2021-12-16	SinoCelltech Ltd	view
JYSB2101212	阿达木单抗注射液	adalimumab	Injection	Biological Products	Supplementary Application	2021-12-28		view